Integrated Vaccine Complex
Genesis of Integrated vaccines Complex:
The National Health Policy (NHP) 2002 of India envisages that the National Program for Universal Immunization against Preventable Diseases requires to be assured of an uninterrupted supply of vaccines at an affordable price. To ensure adequate supply of affordable vaccine for the program, National Health Policy (NHP) stipulates that not less than 50% of the vaccines shall be sourced from public sector institutions. The absence of adequate vaccine production in public sector in the country has led to a widening gap in demand and supply of cost effective vaccines. To strengthen the public sector institution in vaccine manufacturing, Government of India (GOI) had drawn an ambitious plan in setting up the Integrated Vaccines Complex (IVC).
HLL in its quest to become a comprehensive player in the field of healthcare had stated its intent to set up a vaccine manufacturing plant and approached the Ministry of Health and Family Welfare (MoHFW) for allotting adequate land for setting up the venture. Based on a need assessment, it was decided to set up a state-of-the art vaccine manufacturing unit with full-fledged R&D and testing laboratories. The Public Investment Board (PIB) on 10th February 2012 approved the project submitted by HLL Lifecare Limited (HLL) and directed the company to form a 100% subsidiary to implement the project. Near Chennai 100 acres of land at Chengalpattu, has been earmarked and transferred to HLL, by the Ministry of Health & Family Welfare (MoHFW) for this project. HLL Lifecare Limited has formed a 100% subsidiary company, HLL Biotech Limited to execute the project.
The new vaccine facility of HLL Biotech Limited will manufacture and supply cost effective UIP vaccines to the country and plans to export to agencies including UNICEF by making cost effective and quality vaccines.